Skretting invests $US6.1 million in construction of new shrimp research facility in Ecuador

Shrimp is the fastest growing aquaculture protein and is expected to grow globally around 4-5% per annum over the coming years. To support the sector with the latest R&D, Skretting is constructing a new facility in Ecuador to complement the Skretting Aquaculture Research Centre (ARC) network.

The new facility, named Skretting ARC Guayas Research Station, will be located next to the recently completed Skretting Ecuador feed manufacturing plant. The new R&D facility, centrally coordinated by Skretting ARC in Norway, will comprise fully equipped laboratories and state-of-the art experimental units to carry out trials under controlled conditions. In addition, green-water tanks will ensure maximum applicability under production conditions.

“We are committed to supporting the growth of the shrimp industry globally,” says Alex Obach, Skretting R&D Director. “We also know the importance of optimal diets, combined with high post-larvae quality and professional farming practices. The development of solutions requires world-class R&D facilities, combined with local expertise.”

We are committed to supporting the growth of the shrimp industry globally.
Alex Obach, Skretting R&D Director

Carlos Miranda, Skretting LatAm General Manager says, “In Ecuador, Skretting is recognised by our customers for our high performance diets and expert technical service, including our Skretting 360+ program. We have best-in-class feed facilities, supported by the best R&D; not to mention a world-class genetics program together with Hendrix Genetics and supported by Nutreco. However, we do not rest. We are serious about our commitment to drive the Ecuadorian shrimp industry further and help our clients deliver to the most demanding global shrimp markets."

Skretting ARC currently has research facilities in Norway, Italy, Japan, Chile and China, and additional validation facilities around the globe. With experts in the field of shrimp research, a team of 140 highly skilled specialists and an annual R&D investment of $18 million, Skretting ARC is perfectly positioned to drive innovation in the sector even further.

"Over the years our scientists, together with our extensive research network, have contributed to the launch of important feed solutions for all the shrimp life stages,” continues Obach. “Now, we want to go further. This new world-class shrimp research facility will drive our knowledge of shrimp nutrition in Skretting and deliver new solutions to improve shrimp performance: faster growth, shorter production cycles and higher survival rates. We are excited to see where our curiousity takes us on the next part of our journey."

Stories on investments

Proteon phage image
9 August 2021

Nutreco invests in Proteon Pharmaceuticals

Proteon Pharmaceuticals today announced the completion of its latest investment round, which aims to accelerate commercialisation of its products in aquaculture and livestock farming, as well as to further develop its microbiome platform technology.

Read the article
Fish farmer Nigeria
8 August 2021

Skretting to expand footprint in East Africa with latest investment from Nutreco

Nutreco announced earlier this week that it has formed two joint ventures with the largest animal feed producer in East Africa, Kenya-based Unga Group Plc, to meet the growing demand for high-quality protein within the East African region.

Read the article
24 May 2021

Skretting Australia to expand production capacity in Tasmania

Today, Nutreco’s aquaculture division Skretting announces its intention to expand its production capacity through the purchase of Ridley’s extrusion facility in Westbury, Tasmania. This is a continuation of Skretting’s long-term commitment to the Australian and New Zealand aquaculture industries.

Read the article